Mostrar el registro sencillo del ítem

dc.creatorDardiotis E., Sokratous M., Tsouris Z., Siokas V., Mentis A.-F.A., Aloizou A.-M., Michalopoulou A., Bogdanos D.P., Xiromerisiou G., Deretzi G., Kountouras J., Hadjigeorgiou G.M.en
dc.date.accessioned2023-01-31T07:51:13Z
dc.date.available2023-01-31T07:51:13Z
dc.date.issued2020
dc.identifier10.1111/eci.13218
dc.identifier.issn00142972
dc.identifier.urihttp://hdl.handle.net/11615/73102
dc.description.abstractBackground: Helicobacter pylori (H pylori) is a Gram-negative bacterium, considered to trigger autoimmune gastrointestinal disorders. This pathogen has also been linked to the autoimmune sequelae in extra-gastrointestinal diseases and peripheral neuropathies. Guillain-Barré syndrome (GBS) is a serious autoimmune demyelinating disorder of peripheral nerves, usually with a post-infectious onset. About 30% of cases of GBS attributed to by Campylobacter jejuni, so, H pylori, could be also involved. Growing evidence suggests the likely involvement of H pylori infection in the development of GBS. The aim of the current study was to therefore estimate the prevalence of H pylori antibodies in GBS. Methods: A search of the literature was performed, using the PUBMED database, until December 2018. Data were extracted from six case-control studies, and a stratification analysis was conducted according to cerebrospinal fluid (CSF) or serum detection material. Results: Among 29 records found, 6 studies met in the inclusion criteria for the meta-analysis. In the CSF subgroup, 105 participants were involved (40 GBS patients and 65 controls), while the serum subgroup included 325 participants (152 GBS and 173 controls). Data were combined using a fixed-effects model. Anti-H pylori IgG were significantly more prevalent in GBS patients compared to controls, in both CSF (95% CI: 9.66-186.56, OR: 42.45, Pz <.00001) and serum (95% CI: 1.30-4.11, OR: 2.31, Pz:.004) subgroups. Conclusion: The present meta-analysis showed a strong association between GBS and the presence of H pylori antibodies, especially in CSF, thereby suggesting a role of H pylori infection in the pathophysiology of GBS. © 2020 Stichting European Society for Clinical Investigation Journal Foundationen
dc.language.isoenen
dc.sourceEuropean Journal of Clinical Investigationen
dc.source.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85082189493&doi=10.1111%2feci.13218&partnerID=40&md5=38b1c32da57f0a3ca46813e795433ad4
dc.subjectbacterium antibodyen
dc.subjectHelicobacter pylori antibodyen
dc.subjectimmunoglobulin G antibodyen
dc.subjectunclassified drugen
dc.subjectbacterium antibodyen
dc.subjectimmunoglobulin Gen
dc.subjectantibody blood levelen
dc.subjectArticleen
dc.subjectcerebrospinal fluiden
dc.subjectdisease associationen
dc.subjectGuillain Barre syndromeen
dc.subjectHelicobacter infectionen
dc.subjecthumanen
dc.subjectmeta analysisen
dc.subjectprevalenceen
dc.subjectpriority journalen
dc.subjectblooden
dc.subjectGuillain Barre syndromeen
dc.subjectHelicobacter infectionen
dc.subjectHelicobacter pylorien
dc.subjectimmunologyen
dc.subjectAntibodies, Bacterialen
dc.subjectGuillain-Barre Syndromeen
dc.subjectHelicobacter Infectionsen
dc.subjectHelicobacter pylorien
dc.subjectHumansen
dc.subjectImmunoglobulin Gen
dc.subjectBlackwell Publishing Ltden
dc.titleAssociation between Helicobacter pylori infection and Guillain-Barré Syndrome: A meta-analysisen
dc.typejournalArticleen


Ficheros en el ítem

FicherosTamañoFormatoVer

No hay ficheros asociados a este ítem.

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem